A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury

NCT00036062 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Distress Syndrome, Adult
Acute Lung Injury

Interventions

DRUG: Sivelestat

Sponsor

Eli Lilly and Company